Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Achieving Undetectable Viral Loads in HIV Management
Chicago, Illinois / September 17-20, 2007
Results in Treatment-naive Patients According to findings from the ARTEMIS (Antiretroviral Therapy with TMC114 Examined in Naive Subjects) trial presented here after 48 weeks’ follow-up, treatment-naive patients receiving the novel...
47th Interscience Conference on Antimicrobial Agents and Chemotherapy
New Era in HIV Management: Reducing Viral Loads Even in Highly Treatment-experienced Patients
Chicago, Illinois / September 17-20, 2007
Like the nucleoside reverse transcriptase inhibitors (NRTIs) and the protease inhibitors (PIs), the new class of integrase inhibitors targets one of three viral enzymes that govern the life cycle of HIV. Phase III trials of the first agent...
47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Initiating Earlier Antiviral Treatment and Avoiding Hypersensitivity Reactions
Chicago, Illinois / September 17-20, 2007
According to Dr. Kathleen Squires, Professor of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, most patients today receive one of three fixed-dose co-formulations as their initial backbone nucleoside reverse...
Based on articles from: CMAJ August 2007;177(5):Online 1-4 Maclean’s Magazine August 27, 2007, pp. 38-42
Addressing the Real Burden of Disease: Supporting Current and Future Vaccination Against Human Papillomavirus
August 2007
Editorial Overview: Alex Ferenczy, MD Professor of Pathology and Obstetrics and Gynecology McGill University and the Sir Mortimer B. Davis-Jewish General Hospital Montreal, Quebec and Eduardo L. Franco, PhD Director, Division of Cancer...
4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
Observations on Novel Strategies Using Mainstay HIV Antiretrovirals
Sydney, Australia / July 22-25, 2007
The longest study to date of an antiretroviral therapy (ART) regimen using fosamprenavir (FPV) (1400 mg q.d.) with low-dose ritonavir (100 mg q.d.) (FPV/r) in ART-naïve HIV/AIDS patients has proven its long-term efficacy and safety....
4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
Pharmacogenetic Screening for Hypersensitivity: Towards Personalized Medicine
Sydney, Australia / July 22-25, 2007
Results from the PREDICT-1 (Prospective Randomised Evaluation of DNA Screening in a Clinical Trial) have provided the highest level of evidence necessary to support the introduction of HLA-B*5701 screening into routine clinical practice....
Based on the following published articles: N Engl J Med May 10, 2007;356(19):1915-27, 1938-43
FUTURE I and FUTURE II: Vaccination Against Human Papillomavirus
Two studies involving over 17,000 women have demonstrated that the new quadrivalent vaccine containing human papillomavirus (HPV) types 6, 11, 16 and 18 offers 98 to 100% protection against cervical, vaginal and vulvar disease caused by the...
Primary Care Today
Adult Immunization in Family Practice: Optimizing Opportunity at Each Clinic Visit
Toronto, Ontario / May 10-12, 2007
Toronto - According to researchers here this week, family physicians need to adopt a more proactive role in the promotion of adult immunization in their own practice. Taking advantage at every office visit to recommend age-appropriate...